Abstract
When administered with heparin and aspirin, the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban was associated with a lower incidence of ischemic events in patients with acute coronary syndromes than in patients who received only heparin and aspirin.
Keywords
TirofibanMedicineUnstable anginaMyocardial infarctionCardiologyAntithromboticInternal medicineEptifibatidePlateletPlatelet membrane glycoproteinAnginaAcute coronary syndromePharmacologyPercutaneous coronary intervention
Affiliated Institutions
Related Publications
Learning from the Recently Completed Oral Glycoprotein IIb/IIIa Receptor Antagonist Trials
Although parenteral therapy with glycoprotein (GP) IIb/IIIa inhibitors has resulted in a reduced risk of death or myocardial infarction in patients with acute coronary syndromes...
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
New strategies for profound inhibition of platelet activity at the injured coronary plaque focus on blockade of the platelet surface membrane glycoprotein IIb/IIIa receptor, whi...
Stroke in Patients With Acute Coronary Syndromes
Background —The incidence of stroke in patients with acute coronary syndromes has not been clearly defined because few trials in this patient population have been large enough t...
Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
In patients with unstable angina and myocardial infarction without ST-segment elevation who were treated with the glycoprotein IIb/IIIa inhibitor tirofiban, the use of an early ...
Clinical and Therapeutic Profile of Patients Presenting With Acute Coronary Syndromes Who Do Not Have Significant Coronary Artery Disease
Background —A proportion of patients who present with suspected acute coronary syndrome (ACS) are found to have insignificant coronary artery disease (CAD) during coronary angio...
Publication Info
- Year
- 1998
- Type
- article
- Volume
- 338
- Issue
- 21
- Pages
- 1488-1497
- Citations
- 1320
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1320
OpenAlex
Cite This
Tatjana Potpara
(1998).
Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction.
New England Journal of Medicine
, 338
(21)
, 1488-1497.
https://doi.org/10.1056/nejm199805213382102
Identifiers
- DOI
- 10.1056/nejm199805213382102